m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer

Overview of attention for article published in Frontiers in oncology, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 14,442 followers.

Pubmed: m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer https://t.co/UOyZ2hSRRf

30 Aug 2021

Reply Repost Favourite

New article: m(6)A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer https://t.co/Erfabw5Cm2 #pancreaticcancer #oncology https://t.co/ZCcowJFKQ8

30 Aug 2021

Reply Repost Favourite

New research: m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer: Objective Pancreatic cancer is one of the most lethal human malignancies. Gemcitabine is widely used… https://t.c

11 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.